Non-high-density lipoprotein and very-low-density lipoprotein cholesterol and their risk predictive values in coronary heart disease

被引:212
|
作者
Liu, Jian [1 ]
Sempos, Christopher T.
Donahue, Richard P.
Dorn, Joan
Trevisan, Maurizio
Grundy, Scott M.
机构
[1] Brock Univ, St Catharines, ON L2S 3A1, Canada
[2] NIH, Bethesda, MD 20892 USA
[3] Univ Buffalo, Buffalo, NY USA
[4] Univ Texas, SW Med Ctr, Dallas, TX USA
来源
AMERICAN JOURNAL OF CARDIOLOGY | 2006年 / 98卷 / 10期
关键词
D O I
10.1016/j.amjcard.2006.06.032
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To determine if non-high-density lipoprotein (HDL) cholesterol is a more useful predictor of coronary heart disease (CHD) risk than low-density lipoprotein (LDL) cholesterol and if very-low-density lipoprotein (VLDL) cholesterol is an independent predictor of CHD risk, data from the Framingham Heart Study (2,693 men, 3,101 women) were used for this analysis. All subjects were aged >= 30 years and free of CHD at baseline, and incident CHD was the end point (618 men, 372 women). Cox proportional-hazards models were used to assess the risk for CHD (relative risks and 95% confidence intervals) on the basis of the joint distribution of LDL cholesterol and non-HDL cholesterol (in milligrams per deciliter), as well as LDL cholesterol, non-HDL cholesterol, and VLDL cholesterol as continuous variables. After multivariate adjustment, within non-HDL cholesterol level, no association was found between LDL cholesterol and the risk for CHD, whereas within LDL cholesterol levels, a strong positive and graded association between non-HDL cholesterol and risk for CHD was observed. When the analysis was repeated within triglyceride levels (< 200 vs 2:200 mg/dl), the risk pattern did not change significantly. Also, VLDL cholesterol was found to be a significant predictor of CHD risk after adjusting for LDL cholesterol at triglyceride levels of < 200 or < 200 mg/dI. In conclusion, these results suggest that nonHDL cholesterol level is a stronger predictor of CHD risk than LDL cholesterol; that is, VLDL cholesterol may play a critical role in the development of CHD. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:1363 / 1368
页数:6
相关论文
共 50 条
  • [21] Reliability of low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B measurement
    Contois, John H.
    Warnick, G. Russell
    Sniderman, Allan D.
    JOURNAL OF CLINICAL LIPIDOLOGY, 2011, 5 (04) : 264 - 272
  • [22] Low Total, Low-Density Lipoprotein, High-Density Lipoprotein, and Non-High-Density Lipoprotein Cholesterol Levels in Patients with Complex Congenital Heart Disease after Fontan Palliation
    Whiteside, Wendy
    Tan, Meng
    Yu, Sunkyung
    Rocchini, Albert
    JOURNAL OF PEDIATRICS, 2013, 162 (06): : 1199 - 1204
  • [23] Low-Density Lipoprotein Cholesterol, Non-High-Density Lipoprotein Cholesterol, Triglycerides, and Apolipoprotein B and Cardiovascular Risk in Patients With Manifest Arterial Disease
    van den Berg, M. Johanneke
    van der Graaf, Yolanda
    de Borst, Gert Jan
    Kappelle, L. Jaap
    Nathoe, Hendrik M.
    Visseren, Frank L. J.
    AMERICAN JOURNAL OF CARDIOLOGY, 2016, 118 (06): : 804 - 810
  • [24] Meta-analysis of serum non-high-density lipoprotein cholesterol and risk of coronary heart disease in the general population
    Liu, Hongtao
    Deng, Xia
    Peng, Yudong
    Zeng, Qiutang
    Song, Zongren
    He, Wenping
    Zhang, Le
    Gao, Gan
    Xiao, Ting
    Yu, Xuedong
    CLINICA CHIMICA ACTA, 2017, 471 : 23 - 28
  • [25] Meta-Analysis of the Relationship Between Non-High-Density Lipoprotein Cholesterol Reduction and Coronary Heart Disease Risk
    Robinson, Jennifer G.
    Wang, Songfeng
    Smith, Brian J.
    Jacobson, Terry A.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 53 (04) : 316 - 322
  • [26] Fasting non-high-density lipoprotein cholesterol and low-density lipoprotein particle size Reply
    Li, Chaoyang
    Ford, Earl S.
    Gidding, Samuel S.
    JOURNAL OF PEDIATRICS, 2012, 160 (03): : 532 - 532
  • [27] Non-high-density lipoprotein cholesterol versus low-density lipoprotein cholesterol as a risk factor for a first nonfatal myocardial infarction
    Farwell, WR
    Sesso, HD
    Buring, JE
    Gaziano, JM
    AMERICAN JOURNAL OF CARDIOLOGY, 2005, 96 (08): : 1129 - 1134
  • [28] Total cholesterol, low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol in atherosclerosis cardiovascular disease and cancer in Chinese male
    Guan, X. M.
    Yang, X. L.
    Han, X.
    Yang, Y. H.
    Liu, Y.
    Li, H. H.
    Zhan, S. Y.
    Wu, S. L.
    Xia, Y. L.
    EUROPEAN HEART JOURNAL, 2017, 38 : 724 - 725
  • [29] SUBOPTIMAL TREATMENT OF LOW DENSITY LIPOPROTEIN CHOLESTEROL IN VERY HIGH RISK PATIENTS WITH STABLE CORONARY HEART DISEASE
    Rallidis, L.
    Vavoulis, P.
    Varounis, C.
    Zolindaki, M.
    Rodolakis, N.
    Papadopoulos, K.
    Georgoula, G.
    Apostolou, T.
    Kremastinos, D.
    ATHEROSCLEROSIS SUPPLEMENTS, 2008, 9 (01) : 238 - 238
  • [30] Discordance of Low-Density Lipoprotein Cholestrol and Non-High-Density Lipoprotein Cholestrol and Coronary Artery Disease Severity
    Kurmus, Ozge
    Erkan, Aycan Fahri
    Ekici, Berkay
    Aslan, Turgay
    Eren, Murat
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2020, 114 (03) : 469 - 475